These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b. Moschos SJ; Kirkwood JM; Konstantinopoulos PA J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613 [No Abstract] [Full Text] [Related]
6. [Recombinant interferon alfa-2b in the treatment of patients with skin melanoma]. Korovin SI Lik Sprava; 1998; (2):139-41. PubMed ID: 9670687 [TBL] [Abstract][Full Text] [Related]
8. Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha. Satzger I; Meier A; Schenck F; Kapp A; Hauschild A; Gutzmer R Int J Cancer; 2007 Dec; 121(11):2562-6. PubMed ID: 17680564 [TBL] [Abstract][Full Text] [Related]
9. Update on the role of adjuvant interferon for high risk melanoma. Agarwala SS; Kirkwood JM Forum (Genova); 2000; 10(3):230-9. PubMed ID: 11007931 [TBL] [Abstract][Full Text] [Related]
10. Counterpoint: The case against adjuvant high-dose interferon-alpha for melanoma patients. Chapman PB J Natl Compr Canc Netw; 2004 Jan; 2(1):69-72. PubMed ID: 19777696 [TBL] [Abstract][Full Text] [Related]
11. Effects of adjuvant interferon-alpha low-dose therapy in melanoma patients on serum inhibin B. Karamfilov T; Wollina U; Hipler UC; Graefe T; Schreiber G J Dermatol; 2000 Oct; 27(10):639-42. PubMed ID: 11092267 [TBL] [Abstract][Full Text] [Related]
12. [Feasability and tolerance of adjuvant treatment of melanoma with immunotherapy according to Kirkwood protocol]. Uwer L; Martin S; Geoffrois L; Schmutz JL Ann Dermatol Venereol; 2005 Jan; 132(1):50-1. PubMed ID: 15746611 [No Abstract] [Full Text] [Related]
13. Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatment. Bramlette TB; Lawson DH; Washington CV; Veledar E; Johns BR; Brisman SF; Abramova L; Chen SC Dermatol Surg; 2007 Jan; 33(1):11-6. PubMed ID: 17214673 [TBL] [Abstract][Full Text] [Related]
15. [Endolymphatic therapy in the treatment of primary delimited melanoblastoma of the skin]. Korovin SI Klin Khir; 1998; (1):39-40. PubMed ID: 9615056 [TBL] [Abstract][Full Text] [Related]